Logo image of DPT.PA

S.T. DUPONT (DPT.PA) Stock Fundamental Analysis

Europe - EPA:DPT - FR0000054199 - Common Stock

0.0986 EUR
0 (0%)
Last: 9/23/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DPT. DPT was compared to 44 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of DPT is average, but there are quite some concerns on its profitability. DPT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year DPT has reported negative net income.
DPT had a positive operating cash flow in the past year.
DPT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DPT reported negative operating cash flow in multiple years.
DPT.PA Yearly Net Income VS EBIT VS OCF VS FCFDPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M

1.2 Ratios

The Return On Assets of DPT (5.67%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 12.00%, DPT is in line with its industry, outperforming 45.45% of the companies in the same industry.
The Return On Invested Capital of DPT (5.99%) is worse than 63.64% of its industry peers.
Industry RankSector Rank
ROA 5.67%
ROE 12%
ROIC 5.99%
ROA(3y)-1.58%
ROA(5y)-8.67%
ROE(3y)-59.93%
ROE(5y)-97.15%
ROIC(3y)N/A
ROIC(5y)N/A
DPT.PA Yearly ROA, ROE, ROICDPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

DPT has a Profit Margin (5.94%) which is comparable to the rest of the industry.
The Operating Margin of DPT (5.34%) is worse than 68.18% of its industry peers.
The Gross Margin of DPT (56.30%) is worse than 65.91% of its industry peers.
DPT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.34%
PM (TTM) 5.94%
GM 56.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.87%
GM growth 5Y4.3%
DPT.PA Yearly Profit, Operating, Gross MarginsDPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DPT is destroying value.
The number of shares outstanding for DPT has been increased compared to 1 year ago.
The number of shares outstanding for DPT has been increased compared to 5 years ago.
Compared to 1 year ago, DPT has an improved debt to assets ratio.
DPT.PA Yearly Shares OutstandingDPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
DPT.PA Yearly Total Debt VS Total AssetsDPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.15 indicates that DPT is not in any danger for bankruptcy at the moment.
The Altman-Z score of DPT (3.15) is comparable to the rest of the industry.
The Debt to FCF ratio of DPT is 4.32, which is a neutral value as it means it would take DPT, 4.32 years of fcf income to pay off all of its debts.
DPT's Debt to FCF ratio of 4.32 is in line compared to the rest of the industry. DPT outperforms 52.27% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that DPT is not too dependend on debt financing.
DPT's Debt to Equity ratio of 0.24 is amongst the best of the industry. DPT outperforms 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 4.32
Altman-Z 3.15
ROIC/WACC0.76
WACC7.9%
DPT.PA Yearly LT Debt VS Equity VS FCFDPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.60 indicates that DPT should not have too much problems paying its short term obligations.
DPT has a better Current ratio (1.60) than 65.91% of its industry peers.
DPT has a Quick Ratio of 1.01. This is a normal value and indicates that DPT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.01, DPT is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.01
DPT.PA Yearly Current Assets VS Current LiabilitesDPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 418.18% over the past year.
DPT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.61%.
The Revenue has been growing slightly by 4.98% on average over the past years.
EPS 1Y (TTM)418.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%205.26%
Revenue 1Y (TTM)6.61%
Revenue growth 3Y15.21%
Revenue growth 5Y4.98%
Sales Q2Q%11.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DPT.PA Yearly Revenue VS EstimatesDPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
DPT.PA Price Earnings VS Forward Price EarningsDPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DPT is valued a bit more expensive than the industry average as 72.73% of the companies are valued more cheaply.
68.18% of the companies in the same industry are cheaper than DPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.82
EV/EBITDA 15.01
DPT.PA Per share dataDPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

S.T. DUPONT

EPA:DPT (9/23/2025, 7:00:00 PM)

0.0986

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners90.6%
Ins Owner ChangeN/A
Market Cap93.05M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.64
P/FCF 34.82
P/OCF 18.15
P/B 3.31
P/tB 3.46
EV/EBITDA 15.01
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY2.87%
OCF(TTM)0.01
OCFY5.51%
SpS0.06
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.67%
ROE 12%
ROCE 8.15%
ROIC 5.99%
ROICexc 7.89%
ROICexgc 8.24%
OM 5.34%
PM (TTM) 5.94%
GM 56.3%
FCFM 4.7%
ROA(3y)-1.58%
ROA(5y)-8.67%
ROE(3y)-59.93%
ROE(5y)-97.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.87%
GM growth 5Y4.3%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 4.32
Debt/EBITDA 1.05
Cap/Depr 73.68%
Cap/Sales 4.32%
Interest Coverage 8.32
Cash Conversion 80.51%
Profit Quality 79.1%
Current Ratio 1.6
Quick Ratio 1.01
Altman-Z 3.15
F-Score5
WACC7.9%
ROIC/WACC0.76
Cap/Depr(3y)135.98%
Cap/Depr(5y)90.75%
Cap/Sales(3y)6.98%
Cap/Sales(5y)5.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)418.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%205.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.61%
Revenue growth 3Y15.21%
Revenue growth 5Y4.98%
Sales Q2Q%11.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2997.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y140.45%
FCF growth 3Y-18.27%
FCF growth 5YN/A
OCF growth 1Y849.44%
OCF growth 3Y-5.46%
OCF growth 5Y29.81%